Trinity Life Sciences Acquires D Cube Analytics

Acquisition Adds Extensive Data Science and Technology Capabilities to Trinity’s Growing Commercialization Portfolio

WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the acquisition of Illinois-headquartered D Cube Analytics. The acquisition adds extensive data science and digital transformation capabilities to Trinity’s growing commercialization portfolio. D Cube’s bespoke analytics platforms, purpose built for life sciences companies, help extract maximum value out of data investments and facilitate decision-making to achieve commercial outcomes more effectively and efficiently.

“Our strategy to revolutionize the life sciences commercial model includes embracing data science. D Cube brings us high-value, innovative technology platforms that will allow our clients to accelerate their brand strategies,” said David Fitzhenry, CEO of Trinity Life Sciences. “We are excited to add the D Cube team and their best-in-class offerings to our business.”

“The amount of innovation in the life sciences analytics space for the commercialization of products is growing at an exponential rate,” said Neal Dunn, Senior Partner, Analytics. “The D Cube acquisition allows Trinity to accelerate our already growing analytics practice with more deployable technology and proven machine learning models. It also provides Trinity with the scale and tools to help our clients shape and define how and when they should use analytics in a meaningful way – strong analytics will be key to all successful brands.”

“The synergies that D Cube and Trinity share are clear,” said Vijay Nandakumar, co-founder and CEO of D Cube Analytics. “Life sciences companies are at the cusp of a data science revolution where the needs go far beyond clean, transparent and easy-to-manage data. The focus is on insights and speed of responsiveness to market dynamics. Our suite of capabilities combined with Trinity’s strategic therapeutic and commercial expertise offer clients the total package.”

“It was important for us to find a company that had a similar culture as D Cube Analytics and put clients first. Trinity’s purpose – every decision impacts a life – really spoke to us and aligned with our goals,” said Dr. Ajay Chandhok, co-founder and President of D Cube Analytics. “We all know why we get up in the morning – to help life sciences companies make decisions that bring successful life-changing and life-saving treatments to market.”

D Cube Analytics deploys data and cloud agnostic technology that allows life sciences companies not only to integrate, manage and analyze their data but also to focus on quick insights-based decision-making to effectively achieve business outcomes.

With 250+ employees, D Cube Analytics’ senior leadership (including Mr. Nandakumar and Dr. Chandhok) and staff will remain on with Trinity. The acquisition significantly expands Trinity’s India footprint, adding offices in Bengaluru and Chennai.

William Blair acted as exclusive financial advisor, Burke Warren acted as legal counsel and Vertices Partners acted as India Counsel for D Cube Analytics.

About D Cube Analytics

D Cube Analytics supports commercial leaders, digital transformation leaders, brand managers and other functional leads on their journey from data to commercial insights. The company leverages cutting edge technology, AI/ML and deep industry expertise to provide the analytics, insights and outcomes necessary to develop a deep understanding of patients, physicians and payers and build a superior commercial and clinical value proposition in the market. D Cube Analytics offers end-to-end biopharma data and analytics solutions. Their products, applications and services drive unparalleled commercial insights for life sciences companies. D Cube platforms include DDS Terra™, DDS IRIS™, DDS Unity™, DDS Cosmos™ and the newly launched DDS Commercial Insights Cloud™.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit


For more information:
Elizabeth Marshall

Trinity Life Sciences


error: Content is protected !!